Histocell

Histocell is a Spanish biopharmaceutical CDMO with over 20 years of experience in regenerative medicine, specializing in cell therapies, biologics (secretomes and exosomes), and advanced medical devices. A key part of its business is Contract Development and Manufacturing Organization (CDMO) services, providing high-quality development, manufacturing, and support for advanced therapy medicinal products (ATMPs).

Histocell’s CDMO services cover mesenchymal stem cells (MSC), induced pluripotent stem cells (iPSC), exosomes, CAR-T and NK cells, cell banks, sterile products, and secretomes. Its expertise spans the entire product lifecycle, from process development and scale-up to clinical and commercial manufacturing, quality control, fill & finish, cryopreservation, and distribution.

With GMP-certified facilities in Larrabetzu, Spain, and an MIA manufacturing authorization (No. 1174), Histocell ensures top-tier standards for clinical and commercial production. Its comprehensive services make it a trusted partner for biotech and pharmaceutical companies developing cell-based therapies and biologics, helping bring next-generation treatments to market.